PERK inactivation, due to the generation of mutations in its kinase domain, impairs cell survival under extreme hypoxia, and PERK promotes cancer cell proliferation by limiting oxidative DNA damage through ATF4 [46]. The gene discussed is EIF2AK3; the disease is cancer.